These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23410164)

  • 21. Improving the efficacy-safety balance of polypharmacology in multi-target drug discovery.
    Ravikumar B; Aittokallio T
    Expert Opin Drug Discov; 2018 Feb; 13(2):179-192. PubMed ID: 29233023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multitarget drug discovery projects in CNS diseases: quantitative systems pharmacology as a possible path forward.
    Geerts H; Kennis L
    Future Med Chem; 2014; 6(16):1757-69. PubMed ID: 25574530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Automating drug discovery.
    Schneider G
    Nat Rev Drug Discov; 2018 Feb; 17(2):97-113. PubMed ID: 29242609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Harnessing Polypharmacology with Medicinal Chemistry.
    Bolognesi ML
    ACS Med Chem Lett; 2019 Mar; 10(3):273-275. PubMed ID: 30891125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemistry-enabled drug delivery (prodrugs): recent progress and challenges.
    Clas SD; Sanchez RI; Nofsinger R
    Drug Discov Today; 2014 Jan; 19(1):79-87. PubMed ID: 23993918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Re-formulating drugs and vaccines for intranasal delivery: maximum benefits for minimum risks?
    Watts PJ; Smith A
    Drug Discov Today; 2011 Jan; 16(1-2):4-7. PubMed ID: 21074635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug discovery beyond the rule of 5 - Opportunities and challenges.
    Doak BC; Kihlberg J
    Expert Opin Drug Discov; 2017 Feb; 12(2):115-119. PubMed ID: 27883294
    [No Abstract]   [Full Text] [Related]  

  • 28. Learning lessons from drugs that have recently entered the market.
    Teague SJ
    Drug Discov Today; 2011 May; 16(9-10):398-411. PubMed ID: 21414418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is the pharmaceutical industry's preoccupation with the monotherapy drug model stifling the development of effective new drug therapies?
    Cock IE
    Inflammopharmacology; 2018 Jun; 26(3):861-879. PubMed ID: 29736688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Addressing the medicinal chemistry bottleneck: a lean approach to centralized purification.
    Weller HN; Nirschl DS; Paulson JL; Hoffman SL; Bullock WH
    ACS Comb Sci; 2012 Sep; 14(9):520-6. PubMed ID: 22909004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current trends in epigenetic drug discovery.
    Stolfa DA; Einsle O; Sippl W; Jung M
    Future Med Chem; 2012 Oct; 4(16):2029-37. PubMed ID: 23157236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Refining the chemical toolbox to be fit for educational and practical purpose for drug discovery in the 21st Century.
    Lolli M; Narramore S; Fishwick CW; Pors K
    Drug Discov Today; 2015 Aug; 20(8):1018-26. PubMed ID: 25959506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of fragment-based and computational methods in polypharmacology.
    Bottegoni G; Favia AD; Recanatini M; Cavalli A
    Drug Discov Today; 2012 Jan; 17(1-2):23-34. PubMed ID: 21864710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Editorial: Hybrid Compounds as Multitarget Agents in Medicinal Chemistry - Part I.
    Scotti L; Mendonca-Junior FJ; Scotti MT
    Curr Top Med Chem; 2017; 17(8):843-844. PubMed ID: 28406078
    [No Abstract]   [Full Text] [Related]  

  • 35. From hybrid compounds to targeted drug delivery in antimalarial therapy.
    Oliveira R; Miranda D; Magalhães J; Capela R; Perry MJ; O'Neill PM; Moreira R; Lopes F
    Bioorg Med Chem; 2015 Aug; 23(16):5120-30. PubMed ID: 25913864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The animal rule: The role of clinical pharmacology in determining an effective dose in humans.
    Bergman KL
    Clin Pharmacol Ther; 2015 Oct; 98(4):365-8. PubMed ID: 26082064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploring polypharmacology using a ROCS-based target fishing approach.
    AbdulHameed MD; Chaudhury S; Singh N; Sun H; Wallqvist A; Tawa GJ
    J Chem Inf Model; 2012 Feb; 52(2):492-505. PubMed ID: 22196353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coping with polypharmacology by computational medicinal chemistry.
    Schneider G; Reker D; Rodrigues T; Schneider P
    Chimia (Aarau); 2014 Sep; 68(9):648-53. PubMed ID: 25437786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human disease and drug pharmacology, complex as real life.
    Viayna E; Sola I; Di Pietro O; Muñoz-Torrero D
    Curr Med Chem; 2013; 20(13):1623-34. PubMed ID: 23410162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. From fragment to clinical candidate--a historical perspective.
    Chessari G; Woodhead AJ
    Drug Discov Today; 2009 Jul; 14(13-14):668-75. PubMed ID: 19427404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.